Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$32.36 n/a | n/a%
07/02/15 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 32.36
52 Week High 33.84
52 Week Low 19.31
Avg. Daily Vol. (Mil) 0.25
Beta (3 year) 0.88
Share Related Items
Mkt Cap (Mil) 1,241.22
Shares Out (Mil) 38.36
Float (Mil) 30.33
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.70
Current Ratio 5.10
LT Debt/ Equity 0.47
Total Debt / Equity 0.47
Valuation Ratios
Price Earnings 49.00
Price/Sales 2.70
Price/Book 2.31
Price/Cash Flow 17.80
Per Share Data
Earnings 0.66
Sales 11.99
Book Value 14.02
Cash Flow 1.81
Business Summary
Emergent BioSolutions Inc is a specialty biopharmaceutical company operating in two divisions: Biodefense and Biosciences. Its products include BioThrax, BAT, Anthrasil, VIGIV, RSDL, NuThrax, PreviThrax and GC-072.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 1280
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 3.93
Previous Month (Mil) 3.63
Short Interest Ratio (Days) 16.10
Management Effectiveness
Return on Equity 6.60
Return on Assets 3.90
Return on Investments 4.50
Profitability
Gross Margin 81.70
EBIT Margin 12.60
Profit Margin 7.70

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter